Download vitamin b1 - Bimeda Ireland

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Pharmaceutical marketing wikipedia , lookup

Environmental persistent pharmaceutical pollutant wikipedia , lookup

Environmental impact of pharmaceuticals and personal care products wikipedia , lookup

Bilastine wikipedia , lookup

Transcript
PRODUCT INFORMATION
VITAMIN B1
Thiamine Hydrochloride
INDICATIONS
For the treatment of cerebrocortical necrosis in cattle
and sheep and as an adjunct in metabolic disorders in
cattle.
BENEFITS
• Treats cerebrocortical necrosis in cattle and
sheep and as an adjunct in metabolic
disorders in cattle
• Can be administered by IM or slow IV
• No undesirable effects noted during
pregnancy or lactation
• Nil withdrawals
PACKAGING
LIST NO.
UNIT PACKAGE
CASE SIZE
1VIT003
50ml
12
See reverse side for Administration and Dosage.
Bimeda®
Broomhill Road
Tallaght
Dublin 24, Ireland
Tel: 1850-515253 Fax: 01 451 5803
www.bimeda.ie
TECHNICAL INFORMATION
VITAMIN B1 INJECTION
PRESENTATION
A clear, sterile aqueous solution
for parenteral administration. Each
ml
contains
100mg
Thiamine
Hydrochloride. Also contains Benzyl
Alcohol (preservative).
USES
For the treatment of cerebrocortical
necrosis in cattle and sheep and as an
adjunct in metabolic disorders in cattle.
DOSAGE AND ADMINISTRATION
To be administered by intramuscular or
slow intravenous injection.
Cattle and sheep for cerebrocortical
necrosis: 2.5 - 5ml per 50kg bodyweight.
Repeat every 3 hours for up to a total of
5 doses.
CONTRAINDICATIONS, WARNINGS
ETC.
For animal treatment only.
Not to be used in animals known to be
hypersensitive to the active ingredient.
Intravenous injections should be given
slowly (over 20 seconds).
Observe aseptic techniques.
It is not anticipated that the use of
Vitamin B1 Injection will lead to any
undesirable effects during pregnancy
and/or lactation.
PHARMACEUTICAL PRECAUTIONS
Keep out of reach and sight of children.
Do not store above 25°C and protect
from light.
Following withdrawal of the first dose,
use the product within 28 days. Unused
product or waste material should be
disposed of in accordance with current
practice for pharmaceutical waste under
national waste disposal regulations.
Avoid the introduction of contamination
during use.
Should any apparent growth or
discoloration occur the product should
be discarded.
LEGAL CATEGORY
POM
PACKAGE QUANTITIES: Multi-dose vials of 50ml.
VPA 10126/050/001
WITHDRAWAL PERIODS
Meat/Milk: Nil.
www.bimeda.ie